EP3927192A1 - Smoking substitute consumable - Google Patents
Smoking substitute consumableInfo
- Publication number
- EP3927192A1 EP3927192A1 EP20704302.7A EP20704302A EP3927192A1 EP 3927192 A1 EP3927192 A1 EP 3927192A1 EP 20704302 A EP20704302 A EP 20704302A EP 3927192 A1 EP3927192 A1 EP 3927192A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- article
- derivatives
- homologues
- plant material
- aerosol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES OF CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D1/00—Cigars; Cigarettes
- A24D1/18—Selection of materials, other than tobacco, suitable for smoking
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES OF CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D1/00—Cigars; Cigarettes
- A24D1/20—Cigarettes specially adapted for simulated smoking devices
Definitions
- the present disclosure relates to an article/consumable for use in a smoking substitute system and particularly, although not exclusively, to a heat-not-burn (HNB) consumable.
- HNB heat-not-burn
- cannabis also known as marijuana or hashish
- cannabis is widely known for both medicinal and recreational purposes.
- recreational use of cannabis has been legalized, or is officially tolerated.
- Cannabis comprises numerous (phyto-)cannabinoids some of which can act on human cannabinoid receptors (CBi and CB2) to affect physiological processes such as appetite, mood, stress response and muscular/joint pain relief.
- CBi and CB2 human cannabinoid receptors
- Ingestion of cannabis is typically through smoking (either alone or mixed with tobacco) and is considered to expose a smoker to potentially harmful substances. It is generally thought that a significant amount of the potentially harmful substances are generated through the heat caused by the burning and/or combustion of the cannabis (and tobacco) and the constituents of the burnt cannabis (and tobacco) in the smoke itself.
- Conventional cannabis smoking articles often referred to as“joints” are typically rolled by hand by the user and comprise a roughly cylindrical wad of dried cannabis leaves/buds/flowers which is surrounded by a paper wrapper.
- a filter may or may not be included, axially aligned in an abutting relationship with the wrapped cannabis wad.
- a conventional cannabis smoking article of this type is used by lighting the end opposite to the filter, and burning the cannabis wad. The smoker receives mainstream smoke into their mouth by drawing on the filter end of the article.
- Combustion of organic material such cannabis is known to produce potentially harmful by-products. Furthermore, some medicinal effects of cannabis are decreased by combustion which can deactivate certain cannabinoids. There have been proposed various smoking substitute systems (or“substitute smoking systems”) in order to avoid the smoking of cannabis.
- Smoking substitute systems for cannabis include heat-not-burn (HNB) systems in which a heater heats ground, chopped or loose leaf cannabis plant material contained within a sealed container pod or capsule to produce an aerosol (also referred to as a“vapour”) that is drawn into the lungs through the mouth (inhaled) and then exhaled.
- HNB heat-not-burn
- aerosol also referred to as a“vapour”
- the inhaled aerosol typically bears cannabinoids without, or with fewer of, the odour and health risks associated with traditional cannabis smoking.
- the present disclosure relates to an aerosol-forming article e.g. a consumable for use in a smoking substitute system and particularly, although not exclusively, to a heat-not-burn (HNB) consumable, wherein the article/consumable comprises a substrate at least partly formed of an extruded plant material.
- HNB heat-not-burn
- an aerosol-forming article comprising an aerosol-forming substrate at least partly formed of extruded cannabinoid-containing plant material.
- the aerosol-forming substrate is capable of being heated to release at least one cannabinoid compound (e.g. a mixture of cannabinoid compounds) that can form a vapour/aerosol.
- Extruded plant material is typically more compacted/more dense than othertypes of plant material typically used in smoking substitute articles.
- the vapour/aerosol will have a higher cannabinoid content than the ground, chopped or loose leaf plant material used in known articles. In turn, this will provide an increased medicinal or recreational effect to the user.
- Cannabinoid compounds include phyto-cannabinoids which include:
- CBD cannabidiol
- CBDV cannabidiol mono(m)ethyl ether
- CBDV cannabidivarin
- CBDV cannabidiorcol
- CBDV cannabidivarilic acid
- CBDN cannabinodiol
- its derivatives/homologues e.g. carrabinodivarin
- CBD cannabigerol
- CBG cannabigerol
- its derivatives/homologues e.g. cannabigerol mono(m)ethyl ether, cannabinerolic acid A, cannabigerovarin, cannabigerolic acid A, cannabigerolic acid A mono(m)ethyl ether, cannabigerovarinic acid A);
- cannabinol CBN
- CBV cannabivarin/cannabivarol
- cannabiorcol cannabinolic acid
- cannabinol methyl ester
- THC tetrahydrocannabinol
- tetrahydrocannabivarin tetrahydrocannabivarin
- tetrahydrocannabiorcol tetrahydrocannabiorcol
- tetrahydrocannabinolic acid A/B tetrahydrocannabivarinic acid A
- tetrahydrocannabiorcolic acid A/B isotetrahydrocannabinol
- isotetrahydrocannabivarin isotetrahydrocannabivarin
- CBD cannabicyclol
- derivatives/homologues e.g. cannabicyclolic acid, cannabicyclovarin
- CBC cannabichromene
- CBCV cannabichromevarin
- CBCV cannabichromevarinic acid A
- CBDE cannabielsoin
- CBE cannabielsoic acid A B, cannabiglendol, dehydrocannabifuran, cannabifuran
- CBD cannabicitran
- cannabitriol and its derivatives/homologues e.g. ethyl cannabitriol, dihydroxy- tetrahydrocannabinol, cannabidiolic acid
- a cannabitriol ester, dihydroxy-hexahydrocannabinol (cannabiripsol), cannabitetrol, oxo-tetrahydrocannabinol e.g. ethyl cannabitriol, dihydroxy- tetrahydrocannabinol, cannabidiolic acid
- CBCN cannabichromanone
- derivatives/homologues e.g. cannabicoumaronone
- the cannabinoid compound is selected from at least one of cannabidiol (CBD) and its derivatives/homologues e.g. cannabiodiol-Cs (CBD-Cs), cannabidiol-C4 (CBD-C4), cannabidiol mono(m)ethyl ether (CBDM-Cs), cannabidivarin (CBDV-C3), cannabidiorcol (CBD-C1), cannabidiolic acid
- CBD-Cs cannabidiol
- CBD-Cs cannabiodiol-Cs
- CBD-C4 cannabidiol-C4
- CBD-C4 cannabidiol mono(m)ethyl ether
- CBDDV-C3 cannabidivarin
- CBD-C1 cannabidiorcol
- CBDA-Cs cannabidivarinic acid
- CBDVA-C3 cannabidivarinic acid
- the cannabinoid compound is selected from at least one of tetrahydrocannabinol (THC) and its derivatives/homologues, e.g. A 9 -tetrahydrocannabinol (A 9 -THC-Cs / c/s-A 9 -THC-C5), D 8 - tetrahydrocannabinol (A 8 -THC-Cs), A 8 -tetrahydrocannabinolic acid A (A 8 -THCA-Cs A), D 9 - tetrahydrocannabinol-C4 (A 9 -THC-C4), A 9 -tetrahydrocannabivarin (A 9 -THCV-C3), A 9 -tetrahydrocannabiorcol (A 9 -THCO-Ci), A 9 -tetrahydrocannabinolic acid A (A 9 -THCA-Cs A), A 9 -
- the total amount of cannabinoid compounds in the substrate may be at least 200 mg; for example, it may be at least 250 mg, at least 300 mg, at least 400 mg, at least 500 mg. In some cases, lower amounts may be preferred.
- the total amount of cannabinoid compounds in the substrate may therefore be at least 10 mg, at least 20 mg, at least 30 mg, at least 40 mg, at least 50 mg, at least 75 mg, at least 100 mg.
- the total amount of cannabinoid compounds may be not more than 200 mg, not more than 175 mg, not more than 150 mg, not more than 125 mg, not more than 100 mg, not more than 75 mg, not more than 50 mg, not more than 40 mg, not more than 30 mg, not more than 20 mg, not more than 10 mg. In some cases, the total amount of the cannabinoid compounds may be not more than 5 mg.
- the total of amount of THC may be limited.
- the total amount of THC in the substrate is not more than 100 mg, not more than 75 mg, not more than 50 mg, not more than 40 mg, not more than 30 mg, not more than 20 mg, not more than 15 mg, not more than 10 mg, not more than 5 mg, not more than 3 mg.
- the amount of THC may be 0.1 to 30 mg, for example 1 to 30 mg, for example 1 to 20 mg, for example 1 to 10 mg, for example 1 to 5 mg, for example 1 to 3 mg.
- the cannabinoid-containing plant material may comprise cannabis plant material including Cannabis sativa, Cannabis indica and Cannabis rudealis.
- the cannabinoid-containing plant material may comprise Echinacea purpurea, Echinacea angustifolia, Acmella oleracea, Helichrysum umbraculigerum, or Radula marginata. This also includes blends of the above mentioned plant material.
- the cannabinoid-containing plant material is cannabis.
- the cannabinoid-containing (e.g. cannabis) plant may be a traditional strain, or may be a strain bred or other modified (e.g. genetically) to produce certain levels of some cannabinoids compounds, e.g. low levels of THC or high levels of THC.
- the cannabinoid-containing plant material may comprise leaves, stems, roots, bark, seeds, buds and flowers (which may be cured).
- the aerosol-forming substrate may comprise at least 50 wt% plant material, e.g. at least 60 wt% plant material e.g. around 65 wt% plant material.
- the aerosol-forming substrate may comprise 80 wt% or less plant material e.g. 75 or 70 wt% or less plant material.
- the substrate may at least partly comprise a rod of extruded cannabinoid-containing (e.g. cannabis) plant material.
- the rod of extruded cannabinoid-containing (e.g. cannabis) plant material may comprise an axial bore adapted to receive an external heating element.
- an aerosol-forming substrate formed of or comprising a rod of extruded cannabinoid-containing plant material having an empty axial bore for receiving an external heating element, the user of a smoking substitute system having an external heater is provided with an aerosol having an increased concentration of cannabinoid compounds and thus an enhanced medicinal/recreational effect.
- the substrate may at least partly comprise pellets/granules/chips of extruded cannabinoid-containing (e.g. cannabis) plant material. In contrast to powdered plant material, each pellet/chip/granule is of a macroscopic size (e.g. having a smallest dimension of greater than 0.5mm or 1 mm).
- Extruded cannabinoid-containing (e.g. cannabis) plant material can produced by forming a liquid mixture of powered plant material and a binding agent such as a gum (e.g. xanthan, guar, arabic and/or locust bean gum). The liquid mixture is heated and then extruded through a die. The extrudate is dried and then may be subsequently cut into pellets, chips or granules.
- a binding agent such as a gum (e.g. xanthan, guar, arabic and/or locust bean gum).
- the liquid mixture is heated and then extruded through a die.
- the extrudate is dried and then may be subsequently cut into pellets, chips or granules.
- the aerosol-forming article is preferably a heat-not-burn (HNB) consumable.
- HNB heat-not-burn
- the aerosol-forming substrate may be located at an upstream axial end of the article/consumable.
- the terms’’’upstream” and“downstream” are intended to refer to the flow direction of the vapour/aerosol i.e. with the downstream end of the article/consumable being the mouth end or outlet where the aerosol exits the article/consumable for inhalation by the user.
- the upstream end of the article/consumable is the opposing end to the downstream end.
- the aerosol-forming substrate may be at least partly circumscribed by a wrapping layer e.g. a paper wrapping layer.
- the aerosol-forming substrate may be formed in a substantially cylindrical shape such that the article/consumable resembles a conventional cigarette. It may have a diameter of between 5 and 10 mm e.g. between 6 and 9 mm or 6 and 8 mm e.g. around 7 mm. It may have an axial length of between 10 and 15 mm e.g. between 1 1 and 14 mm such as around 12 or 13 mm.
- the article/consumable may comprise one or more of a hollow bore element, a filter element, a spacer element and/or a cooling element downstream of the substrate.
- the hollow bore element comprises a hollow bore which extends the axial length of the hollow bore element.
- the hollow bore element may be a terminal hollow bore element at the downstream/mouth end of the article/consumable. In these embodiments, the hollow bore terminates at the downstream/mouth end of the article/consumable.
- the hollow bore element may be an upstream hollow bore element i.e. upstream of the downstream/mouth end of the article/consumable (but downstream of the substrate).
- the article/consumable may comprise both a terminal and upstream hollow bore element.
- the terminal and upstream hollow bore elements may be axially adjacent one another or may be axially spaced.
- the upstream hollow bore element may be axially adjacent i.e. immediately downstream of the substrate.
- the or each hollow bore element may have an axial bore i.e. aligned with the axis of the hollow bore element.
- the or each hollow bore may have a bore diameter of between 1 and 5 mm, e.g. between 2 and 4 mm or between 2 and 3 mm.
- the or each hollow bore element may be formed of a smoke permeable (porous) material such as cellulose acetate or polypropylene tow, paper or plant material or may be formed of smoke impermeable (non- porous) material e.g. non-porous plastics material.
- a smoke permeable (porous) material such as cellulose acetate or polypropylene tow, paper or plant material
- smoke impermeable (non- porous) material e.g. non-porous plastics material.
- the or each hollow bore element may be circumscribed with a plug wrap e.g. a paper plug wrap.
- the upstream hollow bore element may be at least partly (e.g. entirely) circumscribed by the (paper) wrapping layer.
- the terminal hollow bore element (at the downstream end of the article/consumable) may be joined to the adjacent, upstream elements forming the article/consumable by a circumscribing tipping layer e.g. a tipping paper layer.
- the tipping paper may have an axial length longer than the axial length of the terminal hollow bore element such that the tipping paper completely circumscribes the terminal hollow bore element plus the wrapping layer surrounding any adjacent upstream element.
- the or each hollow bore element may have a substantially cylindrical shape with a diameter substantially matching the diameter of the aerosol-forming substrate (with or without its associated wrapping layer).
- the axial length of the or each hollow bore element may be less than 20 mm, e.g. between 8 and 15 mm, for example between 9 and 13 mm e.g. between 10 and 12 mm.
- the filter element may be a terminal filter element at the downstream/mouth end of the article/consumable.
- the filter element may be an upstream filter element i.e. upstream of the downstream/mouth end of the article/consumable (but downstream of the substrate).
- the article/consumable may comprise both a terminal and upstream filter element.
- the terminal and upstream filter elements may be axially adjacent one another or may be axially spaced.
- the upstream filter element may be axially adjacent i.e. immediately downstream of the substrate.
- the or each filter element is of a smoke permeable (porous) material such as cellulose acetate or polypropylene tow, paper or plant material.
- the or each filter element may be circumscribed with a plug wrap e.g. a paper plug wrap.
- the upstream filter element may be at least partly (e.g. entirely) circumscribed by the (paper) wrapping layer.
- the terminal filter element (at the downstream end of the article/consumable) may be joined to the adjacent, upstream elements forming the article/consumable by a circumscribing tipping layer e.g. a tipping paper layer.
- the tipping paper may have an axial length longer than the axial length of the terminal filter element such that the tipping paper completely circumscribes the terminal filter element plus the wrapping layer surrounding any adjacent upstream element.
- the or each filter element may have a substantially cylindrical shape with a diameter substantially matching the diameter of the aerosol-forming substrate (with or without its associated wrapping layer).
- the axial length of the or each filter element may be less than 20 mm, e.g. between 8 and 15 mm, for example between 9 and 13 mm e.g. between 10 and 12 mm.
- the article/consumable may comprise an aerosol-cooling element which is adapted to cool the aerosol generated from the aerosol-forming substrate (by heat exchange) before being inhaled by the user.
- the aerosol-cooling element will be downstream from the aerosol-forming substrate. For example, it may be between the aerosol-forming substrate and the terminal hollow bore/filter element and/or between the terminal and upstream hollow bore/filter elements.
- the aerosol cooling element may be at least partly (e.g. completely) circumscribed by the (paper) wrapping layer.
- the aerosol-cooling element may be formed of a plastics material selected from the group consisting of polylactic acid (PLA), polyvinyl chloride (PVC), polyethylene (PE) and polyethylene terephthalate (PET).
- the aerosol-cooling element may be formed of a crimped/gathered sheet of material to form a structure having a high surface area with a plurality of longitudinal channels to maximise heat exchange and cooling of the aerosol.
- the aerosol cooling element may have an external diameter of between 5 and 10 mm e.g. between 6 and 9 mm or 6 and 8 mm, e.g. around 7 mm. It may have an axial length of between 10 and 15 mm e.g. between 12 and 14 mm or 13 and 14 mm e.g. around 14 mm.
- the article/consumable may comprise a spacer element that defines a space or cavity or chamber between the aerosol-forming substrate and the downstream end of the article/consumable.
- the spacer acts to allow both cooling and mixing of the aerosol. It may be provided between the aerosol-forming substrate and the terminal hollow bore/filter element and/or between the terminal and upstream hollow bore/filter elements.
- the spacer element may comprise a tubular element e.g. a cardboard tube.
- the spacer element may be at least partly (e.g. entirely) circumscribed by the (paper) wrapping layer.
- the spacer element may have an external diameter of between 5 and 10 mm e.g. between 6 and 9 mm or 6 and 8 mm, e.g. around 7 mm. It may have an axial length of between 10 and 15 mm e.g. between 12 and 14 mm or 13 and 14 mm e.g. around 14 mm.
- a smoking substitute system comprising an aerosol-forming article according to the first aspect and a device comprising a heating element.
- the device may be a HNB device i.e. a device adapted to heat but not combust the aerosol-forming substrate.
- the device may comprise a main body for housing the heating element.
- the heating element may comprise an elongated e.g. rod, tube-shaped or blade heating element.
- the heating element may project into or surround a cavity within the main body for receiving the article/consumable described above.
- the diameter of the axial bore of the extruded rod of cannabinoid-containing (e.g. cannabis) plant material preferably matches the diameter of the elongated rod/tube heater.
- the device e.g. the main body
- an electrical power supply e.g. a (rechargeable) battery for powering the heating element.
- It may further comprise a control unit to control the supply of power to the heating element.
- a method of using a smoking substitute system comprising inserting the article/consumable into the device, and heating the article/consumable using the heating element.
- the method comprises inserting the article/consumable into a cavity within the main body and penetrating the article/consumable with the heating element upon insertion of the article/consumable.
- the heating element may penetrate the aerosol-forming substrate in the article/consumable.
- Figure 1 shows a first embodiment of an HNB consumable
- Figure 2 shows a second embodiment of an HNB consumable
- Figure 3 shows the first embodiment within a device forming an HNB system.
- the HNB consumable 1 comprises an aerosol-forming substrate 2 at the upstream end of the consumable 1 .
- the aerosol-forming substrate 2 comprises a rod-shaped extrudate of cannabis which includes the cannabinoid CBD as a volatile compound.
- the aerosol-forming substrate 2 is formed in a substantially cylindrical shape such that the consumable resembles a conventional cigarette. It has diameter of around 7 mm and an axial length of around 12 mm.
- the extrudate comprises an axial bore 13 which has its axial upstream end at the axial upstream end of the aerosol-forming substrate 2.
- the axial bore 13 extends the entire length of the extrudate and thus has an axial length of 12 mm. It has a bore diameter of around 2mm.
- the aerosol-forming substrate 2 is circumscribed by a paper wrapping layer 3.
- the consumable 1 comprises an upstream hollow bore element 4 and a downstream terminal hollow bore element 5.
- the two elements 4, 5 are spaced by a cardboard spacer tube 6. Both elements 4, 5 are formed of cellulose acetate tow and wrapped with a respective paper plug layer (not shown).
- Both elements 4, 5 have a substantially cylindrical shape.
- the diameter of the upstream hollow bore element 4 matches the diameter of the aerosol-forming substrate 2.
- the diameter of the terminal hollow bore element 5 is slightly larger and matches the combined diameter of the aerosol-forming substrate 2 and the wrapping layer 3.
- the upstream hollow bore element 4 is slightly shorter in axial length than the terminal hollow bore element 5 at an axial length of 10 mm compared to 12 mm for the terminal hollow bore element 5.
- the cardboard tube spacer 6 is longer having an axial length of around 14 mm.
- Each hollow bore element 4, 5 has a hollow, longitudinally extending bore.
- the diameter of the bore in the upstream hollow bore element 4 is slightly larger than the diameter of the bore in the terminal hollow bore element 5 having a diameter of 3 mm compared to 2 mm for the terminal hollow bore element 5.
- the cardboard spacer tube 6 and the upstream hollow bore element 4 are circumscribed by the wrapping layer 3.
- the terminal hollow bore element 5 is joined to the adjacent, upstream elements forming the consumable by a circumscribing paper tipping layer 7.
- the tipping layer 7 encircles the terminal hollow bore element 5 and has an axial length of around 20 mm such that it overlays a portion of the cardboard tube spacer 6.
- Figure 2 shows a second embodiment of a consumable 1” which is the same as the first embodiment except that the wrapping layer 3 does not completely circumscribe the cardboard spacer tube 6 such that there is an annular gap 9 between the tipping layer 7 and the cardboard spacer tube 6 downstream of the end of the wrapping layer 3.
- Figure 3 shows the first embodiment inserted into an HNB device 10 comprising a rod-shaped heating element 20 (shown in dashed lines).
- the heating element 20 projects into a cavity 1 1 within the main body 12 of the device.
- the consumable 1 is inserted into the cavity 1 1 of the main body 12 of the device 10 such that the heating rod 20 is received in the axial bore 13 of the aerosol-forming substrate 2.
- Heating of the cannabis plant material in the aerosol-forming substrate 2 is effected by powering the heating element 20 (e.g. with a rechargeable battery (not shown)).
- the heating element 20 e.g. with a rechargeable battery (not shown)
- moisture and volatile compound e.g. CBD
- the vapour cools within the upstream hollow bore element 4 and the cardboard spacer tube 6, it condenses to form an aerosol containing the volatile compounds for inhalation by the user.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cigarettes, Filters, And Manufacturing Of Filters (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19020085.7A EP3698651A1 (en) | 2019-02-22 | 2019-02-22 | Smoking substitute consumable |
| PCT/EP2020/053717 WO2020169440A1 (en) | 2019-02-22 | 2020-02-13 | Smoking substitute consumable |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP3927192A1 true EP3927192A1 (en) | 2021-12-29 |
| EP3927192C0 EP3927192C0 (en) | 2024-05-15 |
| EP3927192B1 EP3927192B1 (en) | 2024-05-15 |
Family
ID=65576095
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19020085.7A Ceased EP3698651A1 (en) | 2019-02-22 | 2019-02-22 | Smoking substitute consumable |
| EP20704302.7A Active EP3927192B1 (en) | 2019-02-22 | 2020-02-13 | Smoking substitute consumable |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19020085.7A Ceased EP3698651A1 (en) | 2019-02-22 | 2019-02-22 | Smoking substitute consumable |
Country Status (3)
| Country | Link |
|---|---|
| EP (2) | EP3698651A1 (en) |
| PL (1) | PL3927192T3 (en) |
| WO (1) | WO2020169440A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022049575A (en) * | 2020-09-16 | 2022-03-29 | Future Technology株式会社 | Fragrance cartridge |
| GB202108768D0 (en) * | 2021-06-18 | 2021-08-04 | Nicoventures Trading Ltd | Article for use in a non-combustible aerosol provision system |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04011808A (en) * | 2002-05-31 | 2005-09-12 | Univ Mississippi | Transmucosal delivery of cannabinoids. |
| HK1222098A1 (en) * | 2013-11-15 | 2017-06-23 | Jj 206, Llc | Systems and methods for a vaporization device and product usage control and documentation |
| WO2017178958A1 (en) * | 2016-04-10 | 2017-10-19 | Canabolabs | Device and a method for controlled administering of a therapeutic composition to a patient |
| WO2018228131A1 (en) * | 2017-06-14 | 2018-12-20 | 中国健康养生集团有限公司 | Electric heating apparatus, applications thereof, cigarette, aerosol producing apparatus and system |
| GB2569367A (en) * | 2017-12-15 | 2019-06-19 | Nerudia Ltd | A substitute smoking consumable |
-
2019
- 2019-02-22 EP EP19020085.7A patent/EP3698651A1/en not_active Ceased
-
2020
- 2020-02-13 WO PCT/EP2020/053717 patent/WO2020169440A1/en not_active Ceased
- 2020-02-13 PL PL20704302.7T patent/PL3927192T3/en unknown
- 2020-02-13 EP EP20704302.7A patent/EP3927192B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL3927192T3 (en) | 2024-10-07 |
| EP3927192C0 (en) | 2024-05-15 |
| EP3698651A1 (en) | 2020-08-26 |
| EP3927192B1 (en) | 2024-05-15 |
| WO2020169440A1 (en) | 2020-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210378310A1 (en) | Smoking Substitute Consumable | |
| US12376618B2 (en) | Smoking substitute consumable | |
| CN108348009A (en) | Flavor delivery product | |
| WO2020089071A1 (en) | Smoking substitute consumable | |
| TW202025921A (en) | Smoking substitute consumable | |
| EP3873255B1 (en) | Smoking substitute consumable | |
| EP3873253B1 (en) | Smoking substitute consumable | |
| WO2020089085A1 (en) | Smoking substitute consumable | |
| EP3927192B1 (en) | Smoking substitute consumable | |
| WO2020089078A1 (en) | Smoking substitute consumable | |
| WO2020089079A1 (en) | Smoking substitute consumable | |
| TW202023400A (en) | Smoking substitute consumable | |
| WO2020089114A1 (en) | Smoking substitute consumable | |
| EP3782485A1 (en) | Smoking substitute consumable | |
| EP3698652A1 (en) | Smoking substitute consumable | |
| WO2020089086A1 (en) | Smoking substitute consumable | |
| EP3873282A1 (en) | Smoking substitute consumable | |
| WO2020089063A1 (en) | Smoking substitute consumable | |
| EP3873239B1 (en) | Smoking substitute consumable | |
| EP3698653A1 (en) | Smoking substitute consumable | |
| EP4442129A2 (en) | Smoking substitute consumable | |
| WO2020089068A1 (en) | Smoking substitute consumable | |
| WO2020089073A1 (en) | Smoking substitute consumable | |
| EP3782486A1 (en) | Smoking substitute consumable | |
| WO2020089050A1 (en) | Smoking substitute consumable |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20210917 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: IMPERIAL TOBACCO LIMITED |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A24D 1/20 20200101ALI20230821BHEP Ipc: A24D 1/18 20060101ALI20230821BHEP Ipc: A24B 15/16 20200101AFI20230821BHEP |
|
| INTG | Intention to grant announced |
Effective date: 20230914 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602020030897 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| U01 | Request for unitary effect filed |
Effective date: 20240610 |
|
| U07 | Unitary effect registered |
Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI Effective date: 20240624 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240915 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240515 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240515 |
|
| REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20240401845 Country of ref document: GR Effective date: 20241007 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240815 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240915 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240515 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240515 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240815 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240515 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240515 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240515 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240515 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240515 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240515 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602020030897 Country of ref document: DE |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| U20 | Renewal fee for the european patent with unitary effect paid |
Year of fee payment: 6 Effective date: 20250218 |
|
| 26N | No opposition filed |
Effective date: 20250218 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240515 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20250228 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20250213 |
|
| U20 | Renewal fee for the european patent with unitary effect paid |
Year of fee payment: 7 Effective date: 20260121 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20260121 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CZ Payment date: 20260202 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20260123 Year of fee payment: 7 Ref country code: PL Payment date: 20260126 Year of fee payment: 7 |